Armah B, Dies R, Heinz N
Arzneimittelforschung. 1983;33(1):131-5.
The saluretic and diuretic properties of 4-chloro-5-sulfamoyl-2',6'-salicyloxylidide (xipamide) and 2,4,7-triamino-6-phenyl-pteridine (triamterene) were determined in rats following sole and combined application in various dosages and dose ratios. Xipamide dosages ranged from 0.01-30 mg/kg body weight. Xipamide, when given alone, revealed a significant dose-dependent increase in sodium excretion and urine volume compared to control animals even in the smallest dose to be tested (0.01 mg/kg). Triamterene as sole agent led to an increased sodium and water excretion when given in a natriuretic threshold dose of approximately 1.0 mg/kg. Potassium excretion was slightly enhanced following xipamide application and decreased significantly with triamterene treatment. The combined application of xipamide and triamterene in dose ratios of 1:1-1:4 (xipamide/triamterene) resulted in an increased sodium excretion which was almost additive following high triamterene dosages. Potassium elimination decreased significantly when threshold triamterene dosages were added. High triamterene dosages in all dose ratios of the combined application resulted in potassium levels which only could be registered following sole triamterene application.
研究了4-氯-5-氨磺酰基-2',6'-水杨酰替苯胺(氯噻嗪)和2,4,7-三氨基-6-苯基蝶啶(氨苯蝶啶)在大鼠体内单独及联合应用不同剂量和剂量比时的利钠和利尿特性。氯噻嗪的剂量范围为0.01 - 30毫克/千克体重。单独给予氯噻嗪时,即使是最小测试剂量(0.01毫克/千克),与对照动物相比,钠排泄和尿量也呈现出显著的剂量依赖性增加。氨苯蝶啶作为单一药物,以约1.0毫克/千克的利钠阈值剂量给药时,会导致钠和水排泄增加。应用氯噻嗪后钾排泄略有增加,而氨苯蝶啶治疗后钾排泄显著减少。氯噻嗪和氨苯蝶啶以1:1 - 1:4(氯噻嗪/氨苯蝶啶)的剂量比联合应用时,钠排泄增加,在高剂量氨苯蝶啶时几乎呈相加作用。加入阈值剂量的氨苯蝶啶后,钾排泄显著减少。联合应用的所有剂量比中,高剂量氨苯蝶啶导致的钾水平只有在单独应用氨苯蝶啶时才能检测到。